Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Mathurin

Showing results (281-290 of 286) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 286 results.
American Heart Journal|April 15, 2018
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patientsPatrice Cacoub, Pierre Nahon, Richard Layese, et al.
Nature|November 15, 2019
Bacteriophage targeting of gut bacterium attenuates alcoholic liver diseaseYi Duan, Cristina Llorente, Sonja Lang, et al.
Lancet (London, England)|May 2, 2026
Implementing sustainable liver health in Europe: a second EASL-Lancet CommissionTom H Karlsen, Sharon J Hutchinson, Shira Zelber-Sagi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 13, 2022
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohortsIsabelle Ollivier-Hourmand, Yohann Repesse, Pierre Nahon, et al.
Gut|January 7, 2022
Clinical, histological and molecular profiling of different stages of alcohol-related liver diseaseMeritxell Ventura-Cots, Josepmaria Argemi, Patricia D Jones, et al.
Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.
Pageof 29

Showing results (281-290 of 286) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 286 results.
American Heart Journal|April 15, 2018
Prognostic value of viral eradication for major adverse cardiovascular events in hepatitis C cirrhotic patientsPatrice Cacoub, Pierre Nahon, Richard Layese, et al.
Nature|November 15, 2019
Bacteriophage targeting of gut bacterium attenuates alcoholic liver diseaseYi Duan, Cristina Llorente, Sonja Lang, et al.
Lancet (London, England)|May 2, 2026
Implementing sustainable liver health in Europe: a second EASL-Lancet CommissionTom H Karlsen, Sharon J Hutchinson, Shira Zelber-Sagi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 13, 2022
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohortsIsabelle Ollivier-Hourmand, Yohann Repesse, Pierre Nahon, et al.
Gut|January 7, 2022
Clinical, histological and molecular profiling of different stages of alcohol-related liver diseaseMeritxell Ventura-Cots, Josepmaria Argemi, Patricia D Jones, et al.
Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.
Pageof 29